Toward the development of α1a adrenergic receptor antagonists

被引:36
作者
Bock, MG [1 ]
Patane, MA [1 ]
机构
[1] Merck Res Labs, West Point, PA 19486 USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷
关键词
D O I
10.1016/S0065-7743(00)35021-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:221 / 230
页数:10
相关论文
共 84 条
[11]  
BROTEN T, 1999, FASEB J, V13
[12]   PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EFFECT OF PHENOXYBENZAMINE IN BENIGN PROSTATIC OBSTRUCTION [J].
CAINE, M ;
PERLBERG, S ;
MERETYK, S .
BRITISH JOURNAL OF UROLOGY, 1978, 50 (07) :551-554
[13]   PHENOXYBENZAMINE FOR BENIGN PROSTATIC OBSTRUCTION - REVIEW OF 200 CASES [J].
CAINE, M ;
PERLBERG, S ;
SHAPIRO, A .
UROLOGY, 1981, 17 (06) :542-546
[14]   Tamsulosin 0.4 mg once daily: Tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH) [J].
Chapple, CR ;
Baert, L ;
Thind, P ;
Hofner, K ;
Khoe, GSS ;
Spangberg, A .
EUROPEAN UROLOGY, 1997, 32 (04) :462-470
[15]  
Chen TB, 1999, FASEB J, V13, pA141
[16]   α1-blockers for BPH:: Are there differences? [J].
de Mey, C .
EUROPEAN UROLOGY, 1999, 36 :52-63
[17]   Clinical experience in Europe with uroselective α1-antagonists [J].
Debruyne, FMJ ;
Van der Poel, HG .
EUROPEAN UROLOGY, 1999, 36 :54-58
[18]   Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 2.: Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety [J].
Dhar, TGM ;
Nagarathnam, D ;
Marzabadi, MR ;
Lagu, B ;
Wong, WC ;
Chiu, G ;
Tyagarajan, S ;
Miao, SW ;
Zhang, FQ ;
Sun, WY ;
Tian, D ;
Shen, QR ;
Zhang, J ;
Wetzel, JM ;
Forray, C ;
Chang, RSL ;
Broten, TP ;
Schorn, TW ;
Chen, TB ;
O'Malley, S ;
Ransom, R ;
Schneck, K ;
Bendesky, R ;
Harrell, CM ;
Vyas, KP ;
Zhang, KY ;
Gilbert, J ;
Pettibone, DJ ;
Patane, MA ;
Bock, MG ;
Freidinger, RM ;
Gluchowski, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4778-4793
[19]   N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha(1)-adrenoceptor antagonists [J].
Elworthy, TR ;
Ford, APDW ;
Bantle, GW ;
Morgans, DJ ;
Ozer, RS ;
Palmer, WS ;
Repke, DB ;
Romero, M ;
Sandoval, L ;
Sjogren, EB ;
Talamas, FX ;
Vazquez, A ;
Wu, H ;
Arredondo, NF ;
Blue, DR ;
DeSousa, A ;
Gross, LM ;
Kava, MS ;
Lesnick, JD ;
Vimont, RL ;
Williams, TJ ;
Zhu, QM ;
Pfister, JR ;
Clarke, DE .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (17) :2674-2687
[20]   ALPHA-BLOCKADE IN THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA [J].
ERI, LM ;
TVETER, KJ .
JOURNAL OF UROLOGY, 1995, 154 (03) :923-934